The manufacturing program of OZON PHARM is focused on import substitution in the production of medicinal products. Eight medicines, that will be manufactured at the plant in the Togliatti special economic zone, are included in the import substitution plan of pharmaceutical industry approved by the Ministry of Industry and Trade of Russia in 2015.
The list includes such drugs as acyclovir, bisoprolol, indapamide, metformin, nifedipine, omeprazole, fluconazole, and enalapril. Their test production will begin in May.
Currently, OZON PHARM plant is going through pre-commissioning activities. The installed equipment is tested by the representatives of manufacturers. For this purpose, along with local specialists, the plant is visited by their foreign colleagues so that they can check the operability of equipment purchased in Germany and Italy.